Selected research
Market Outlook & Growth Opportunities
Global Whole Genome Sequencing Service Market Outlook and Growth Opportunities 2026
Market perspective
The global Whole Genome Sequencing Service market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for Whole Genome Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Whole Genome Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Whole Genome Sequencing Service is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the Whole Genome Sequencing Service market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the Whole Genome Sequencing Service market include Illumina, BGI Genomics Co.,Ltd., Agilent Technologies, Macrogen, Pacific Biosciences, 10x Genomics, QIAGEN, GEEWIZ and MACROGEN, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.
This report provides an overview of the global Whole Genome Sequencing Service market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Whole Genome Sequencing Service and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Whole Genome Sequencing Service revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Whole Genome Sequencing Service market.
Whole Genome Sequencing Service Segment by Company
Illumina
BGI Genomics Co.,Ltd.
Agilent Technologies
Macrogen
Pacific Biosciences
10x Genomics
QIAGEN
GEEWIZ
MACROGEN
Oxford Nanopore Technologies
Whole Genome Sequencing Service Segment by Type
Dideoxy Sequencing Technology
High-throughput Sequencing Technology
Single Molecule Sequencing Technology
Whole Genome Sequencing Service Segment by Application
Medical Institution
Scientific Research Institutions
Pharmaceutical Companies
Individual User
Whole Genome Sequencing Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global Whole Genome Sequencing Service status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Whole Genome Sequencing Service key companies, revenue, market share, and recent developments.
3. To split the Whole Genome Sequencing Service breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Whole Genome Sequencing Service market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Whole Genome Sequencing Service significant trends, drivers, influence factors in global and regions.
6. To analyze Whole Genome Sequencing Service competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Genome Sequencing Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Whole Genome Sequencing Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Genome Sequencing Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Whole Genome Sequencing Service industry.
Chapter 3: Detailed analysis of Whole Genome Sequencing Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Whole Genome Sequencing Service in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Whole Genome Sequencing Service in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Dideoxy Sequencing Technology
- High-throughput Sequencing Technology
- Single Molecule Sequencing Technology
Applications
- Medical Institution
- Scientific Research Institutions
- Pharmaceutical Companies
- Individual User
Companies covered
- Illumina
- BGI Genomics Co.,Ltd.
- Agilent Technologies
- Macrogen
- Pacific Biosciences
- 10x Genomics
- QIAGEN
- GEEWIZ
- MACROGEN
- Oxford Nanopore Technologies
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Whole Genome Sequencing Service Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Whole Genome Sequencing Service Market Size (2021-2032)
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Whole Genome Sequencing Service Market Dynamics
- 2.1 Whole Genome Sequencing Service Industry Trends
- 2.2 Whole Genome Sequencing Service Industry Drivers
- 2.3 Whole Genome Sequencing Service Industry Opportunities and Challenges
- 2.4 Whole Genome Sequencing Service Industry Restraints
3 Whole Genome Sequencing Service Market by Company
- 3.1 Global Whole Genome Sequencing Service Company Revenue Ranking in 2025
- 3.2 Global Whole Genome Sequencing Service Revenue by Company (2021-2026)
- 3.3 Global Whole Genome Sequencing Service Company Ranking (2024-2026)
- 3.4 Global Whole Genome Sequencing Service Company Manufacturing Base and Headquarters
- 3.5 Global Whole Genome Sequencing Service Company Product Type and Application
- 3.6 Global Whole Genome Sequencing Service Company Establishment Date
- 3.7 Market Competitive Analysis
- 3.7.1 Global Whole Genome Sequencing Service Market Concentration Ratio (CR5 and HHI)
- 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.7.3 2025 Whole Genome Sequencing Service Tier 1, Tier 2, and Tier 3 Companies
- 3.8 Mergers and Acquisitions Expansion
4 Whole Genome Sequencing Service Market by Type
- 4.1 Whole Genome Sequencing Service Type Introduction
- 4.1.1 Dideoxy Sequencing Technology
- 4.1.2 High-throughput Sequencing Technology
- 4.1.3 Single Molecule Sequencing Technology
- 4.2 Global Whole Genome Sequencing Service Sales Value by Type
- 4.2.1 Global Whole Genome Sequencing Service Sales Value by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Whole Genome Sequencing Service Sales Value by Type (2021-2032)
- 4.2.3 Global Whole Genome Sequencing Service Sales Value Share by Type (2021-2032)
5 Whole Genome Sequencing Service Market by Application
- 5.1 Whole Genome Sequencing Service Application Introduction
- 5.1.1 Medical Institution
- 5.1.2 Scientific Research Institutions
- 5.1.3 Pharmaceutical Companies
- 5.1.4 Individual User
- 5.2 Global Whole Genome Sequencing Service Sales Value by Application
- 5.2.1 Global Whole Genome Sequencing Service Sales Value by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Whole Genome Sequencing Service Sales Value by Application (2021-2032)
- 5.2.3 Global Whole Genome Sequencing Service Sales Value Share by Application (2021-2032)
6 Whole Genome Sequencing Service Regional Value Analysis
- 6.1 Global Whole Genome Sequencing Service Sales Value by Region: 2021 VS 2025 VS 2032
- 6.2 Global Whole Genome Sequencing Service Sales Value by Region (2021-2032)
- 6.2.1 Global Whole Genome Sequencing Service Sales Value by Region: 2021-2026
- 6.2.2 Global Whole Genome Sequencing Service Sales Value by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Whole Genome Sequencing Service Sales Value (2021-2032)
- 6.3.2 North America Whole Genome Sequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.4 Europe
- 6.4.1 Europe Whole Genome Sequencing Service Sales Value (2021-2032)
- 6.4.2 Europe Whole Genome Sequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.5 Asia-Pacific
- 6.5.1 Asia-Pacific Whole Genome Sequencing Service Sales Value (2021-2032)
- 6.5.2 Asia-Pacific Whole Genome Sequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.6 South America
- 6.6.1 South America Whole Genome Sequencing Service Sales Value (2021-2032)
- 6.6.2 South America Whole Genome Sequencing Service Sales Value Share by Country, 2025 VS 2032
- 6.7 Middle East & Africa
- 6.7.1 Middle East & Africa Whole Genome Sequencing Service Sales Value (2021-2032)
- 6.7.2 Middle East & Africa Whole Genome Sequencing Service Sales Value Share by Country, 2025 VS 2032
7 Whole Genome Sequencing Service Country-level Value Analysis
- 7.1 Global Whole Genome Sequencing Service Sales Value by Country: 2021 VS 2025 VS 2032
- 7.2 Global Whole Genome Sequencing Service Sales Value by Country (2021-2032)
- 7.2.1 Global Whole Genome Sequencing Service Sales Value by Country (2021-2026)
- 7.2.2 Global Whole Genome Sequencing Service Sales Value by Country (2027-2032)
- 7.3 USA
- 7.3.1 USA Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.3.2 USA Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.3.3 USA Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.4 Canada
- 7.4.1 Canada Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.4.2 Canada Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.4.3 Canada Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.5 Mexico
- 7.5.1 Mexico Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.5.2 Mexico Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.5.3 Mexico Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.6 Germany
- 7.6.1 Germany Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.6.2 Germany Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Germany Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.7 France
- 7.7.1 France Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.7.2 France Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.7.3 France Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.8 U.K.
- 7.8.1 U.K. Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.8.2 U.K. Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.8.3 U.K. Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.9 Italy
- 7.9.1 Italy Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.9.2 Italy Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.9.3 Italy Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.10 Spain
- 7.10.1 Spain Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.10.2 Spain Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.10.3 Spain Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.11 Russia
- 7.11.1 Russia Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.11.2 Russia Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Russia Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.12 Netherlands
- 7.12.1 Netherlands Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.12.2 Netherlands Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Netherlands Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.13 Nordic Countries
- 7.13.1 Nordic Countries Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.13.2 Nordic Countries Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Nordic Countries Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.14 China
- 7.14.1 China Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.14.2 China Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.14.3 China Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.15 Japan
- 7.15.1 Japan Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.15.2 Japan Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Japan Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.16 South Korea
- 7.16.1 South Korea Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.16.2 South Korea Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.16.3 South Korea Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.17 India
- 7.17.1 India Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.17.2 India Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.17.3 India Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.18 Australia
- 7.18.1 Australia Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.18.2 Australia Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.18.3 Australia Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.19 Southeast Asia
- 7.19.1 Southeast Asia Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.19.2 Southeast Asia Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.19.3 Southeast Asia Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.20 Brazil
- 7.20.1 Brazil Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.20.2 Brazil Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Brazil Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.21 Argentina
- 7.21.1 Argentina Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.21.2 Argentina Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Argentina Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.22 Chile
- 7.22.1 Chile Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.22.2 Chile Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Chile Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.23 Colombia
- 7.23.1 Colombia Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.23.2 Colombia Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Colombia Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.24 Peru
- 7.24.1 Peru Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.24.2 Peru Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Peru Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.25 Saudi Arabia
- 7.25.1 Saudi Arabia Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.25.2 Saudi Arabia Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Saudi Arabia Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.26 Israel
- 7.26.1 Israel Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.26.2 Israel Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Israel Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.27 UAE
- 7.27.1 UAE Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.27.2 UAE Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.27.3 UAE Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.28 Turkey
- 7.28.1 Turkey Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.28.2 Turkey Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Turkey Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.29 Iran
- 7.29.1 Iran Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.29.2 Iran Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.29.3 Iran Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
- 7.30 Egypt
- 7.30.1 Egypt Whole Genome Sequencing Service Sales Value Growth Rate (2021-2032)
- 7.30.2 Egypt Whole Genome Sequencing Service Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Egypt Whole Genome Sequencing Service Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 Illumina
- 8.1.1 Illumina Company Information
- 8.1.2 Illumina Business Overview
- 8.1.3 Illumina Whole Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.1.4 Illumina Whole Genome Sequencing Service Product Portfolio
- 8.1.5 Illumina Recent Developments
- 8.2 BGI Genomics Co.,Ltd.
- 8.2.1 BGI Genomics Co.,Ltd. Company Information
- 8.2.2 BGI Genomics Co.,Ltd. Business Overview
- 8.2.3 BGI Genomics Co.,Ltd. Whole Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.2.4 BGI Genomics Co.,Ltd. Whole Genome Sequencing Service Product Portfolio
- 8.2.5 BGI Genomics Co.,Ltd. Recent Developments
- 8.3 Agilent Technologies
- 8.3.1 Agilent Technologies Company Information
- 8.3.2 Agilent Technologies Business Overview
- 8.3.3 Agilent Technologies Whole Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.3.4 Agilent Technologies Whole Genome Sequencing Service Product Portfolio
- 8.3.5 Agilent Technologies Recent Developments
- 8.4 Macrogen
- 8.4.1 Macrogen Company Information
- 8.4.2 Macrogen Business Overview
- 8.4.3 Macrogen Whole Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.4.4 Macrogen Whole Genome Sequencing Service Product Portfolio
- 8.4.5 Macrogen Recent Developments
- 8.5 Pacific Biosciences
- 8.5.1 Pacific Biosciences Company Information
- 8.5.2 Pacific Biosciences Business Overview
- 8.5.3 Pacific Biosciences Whole Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.5.4 Pacific Biosciences Whole Genome Sequencing Service Product Portfolio
- 8.5.5 Pacific Biosciences Recent Developments
- 8.6 10x Genomics
- 8.6.1 10x Genomics Company Information
- 8.6.2 10x Genomics Business Overview
- 8.6.3 10x Genomics Whole Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.6.4 10x Genomics Whole Genome Sequencing Service Product Portfolio
- 8.6.5 10x Genomics Recent Developments
- 8.7 QIAGEN
- 8.7.1 QIAGEN Company Information
- 8.7.2 QIAGEN Business Overview
- 8.7.3 QIAGEN Whole Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.7.4 QIAGEN Whole Genome Sequencing Service Product Portfolio
- 8.7.5 QIAGEN Recent Developments
- 8.8 GEEWIZ
- 8.8.1 GEEWIZ Company Information
- 8.8.2 GEEWIZ Business Overview
- 8.8.3 GEEWIZ Whole Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.8.4 GEEWIZ Whole Genome Sequencing Service Product Portfolio
- 8.8.5 GEEWIZ Recent Developments
- 8.9 MACROGEN
- 8.9.1 MACROGEN Company Information
- 8.9.2 MACROGEN Business Overview
- 8.9.3 MACROGEN Whole Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.9.4 MACROGEN Whole Genome Sequencing Service Product Portfolio
- 8.9.5 MACROGEN Recent Developments
- 8.10 Oxford Nanopore Technologies
- 8.10.1 Oxford Nanopore Technologies Company Information
- 8.10.2 Oxford Nanopore Technologies Business Overview
- 8.10.3 Oxford Nanopore Technologies Whole Genome Sequencing Service Revenue and Gross Margin (2021-2026)
- 8.10.4 Oxford Nanopore Technologies Whole Genome Sequencing Service Product Portfolio
- 8.10.5 Oxford Nanopore Technologies Recent Developments
9 Concluding Insights
10 Appendix
- 10.1 Reasons for Doing This Study
- 10.2 Research Methodology
- 10.3 Research Process
- 10.4 Authors List of This Report
- 10.5 Data Source
- 10.5.1 Secondary Sources
- 10.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst